Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • LITE vs MRNA✓SelectedUSD · MRNALITE vs MRNA performance historyLatest closeAs of-1.59%11/18
Stock and ETF performance explorer

LITE vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+511.8%
MRNA return
-20.0%
Excess return
+531.9%
Maximum drawdown
-66.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.6%-4.8%+3.3%-1.3%
7D-15.0%-20.9%+5.9%-13.8%
30D-34.0%-13.3%-20.7%-33.4%
3M-36.9%+212.6%-249.5%-43.8%
6M-37.7%+309.0%-346.8%-48.1%
YTD+49.5%+567.3%-517.8%+11.5%
1Y+122.7%+689.7%-567.0%+61.1%
3Y+1,147.6%+157.4%+990.2%+948.9%
5Y+511.8%-21.7%+533.5%+450.4%
All+511.8%-20.0%+531.9%+450.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling